- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Britain OKs Human Cloning Study
11 August 2004 (All day)
Human cloning research has been given a green light in the United Kingdom. The Human Fertilisation and Embryology Authority (HFEA), which regulates research involving human embryos in Britain, today granted scientists at the University of Newcastle permission to attempt to create human embryos by nuclear transfer--the same technique used to produce cloned animals.
The Newcastle scientists have no intention to create full-term babies. Instead, they hope to create stem cell lines that might provide insights into genetic diseases or, someday, provide genetically matched stem cells that could treat patients suffering from diabetes or even spinal cord injuries.
First the team will attempt to create a cloned embryo by inserting the nucleus of, say, a skin cell into an unfertilized human egg, left over from in vitro fertilization treatments. If they succeed in creating embryos that develop for a few days, they will remove the outer layer of cells (usually destined to become the placenta) and attempt to grow the so-called inner cell mass in culture dishes. Such cells, called embryonic stem (ES) cells, can grow in culture indefinitely and can in theory become any cell type in the body. Scientists hope to someday be able to use such cells to grow replacement tissues to treat disease.
University of Newcastle embryologist Miodrag Stojkovic, who will lead the research team, says they will start out using nuclei from healthy donors. In the long term, though, he and his colleagues hope to create ES cell lines using nuclei from patients who suffer from genetic diseases such as type I diabetes. Such cell lines could provide valuable insights into the mechanisms behind the disease, he says.
HFEA is the first to grant a license for such work in Europe. The license is limited, and the team must reapply to have it extended beyond 1 year. Scientists in Korea announced in February that they had created a stem cell line from a cloned embryo (ScienceNOW, 12 February). In the United States, federal government funding cannot be used for embryo research, but researchers with private funds are free to attempt human nuclear transfer. Several U.S. teams have tried to create stem cell lines from cloned embryos, but none has announced successful results.